Cargando…

SAT394 Over-representation Of Adoptees Among Transgender Subjects Seeking Gender-Affirming-Hormonal-Therapy (GAHT) In A Large Tertiary Medical Center

Disclosure: I. Yaish: None. G. Keltch: None. Y. Greenman: None. T. Kolitz: None. K.M. Tordjman: None. Background: The etiology of transgenderism is still unclear. Possible mechanisms range from inborn brain-specific anatomical characteristics, to endocrine-related genetic polymorphisms. In addition,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yaish, Iris, Keltch, Gali, Greenman, Yona, Kolitz, Tamara, Tordjman, Karen Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Transgender Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554383/ http://dx.doi.org/10.1210/jendso/bvad114.2065

Ejemplares similares

SAT406 Evaluation Of The Emotional And Cognitive Effects Of Hormone Therapy In Transgender Men And Women
por: Yaish, Iris, et al.
Publicado: (2023)

SAT409 Sublingual Estradiol Only, Compared To Combined Oral Estradiol And Cyproterone Acetate,Offers No Apparent Advantage For Gender Affirming Hormone Therapy (GHAT), In Treatment Naïve Transwomen: Results Of A Prospective Pilot Study
por: Yaish, Iris, et al.
Publicado: (2023)

SAT411 The Influence Of Gender Affirming Hormone Therapy On Markers Of Platelet Activation In Transgender Women
por: van Zijverden, L Mees, et al.
Publicado: (2023)

SAT645 Cardiac Autonomic Modulation In Transgender Men Under Gender-affirming Hormone Therapy
por: Moreira Allgayer, Roberta Martins Costa, et al.
Publicado: (2023)

SAT398 Pubertal Status And Trends In Gender Affirming Treatment Of Transgender And Gender Diverse Youth
por: Lin, Cathy, et al.
Publicado: (2023)

SAT410 Echocardiogram Analysis Of Transgender Women Amateur Athletes Undergoing Gender-affirming Hormone Therapy
por: Mobilia Alvares, Leonardo Azevedo, et al.
Publicado: (2023)

SAT416 The Incidence Of Autoimmune Disease In Transgender People After Initiation Of Gender-Affirming Hormone Therapy
por: Wiepjes, Chantal, et al.
Publicado: (2023)

SAT405 Bone Analysis Of Transgender Women Amateur Athletes Undergoing Gender-affirming Hormone Therapy
por: dos Santos, Lívia Marcela, et al.
Publicado: (2023)

Clinical pearls of gender-affirming hormone therapy in transgender patients
por: Irving, Amanda, et al.
Publicado: (2018)

SAT647 Quantifying The Effects Of Gender-Affirming Hormone Therapy On Bone Density Of Transgender Patients: Emerging Results Of A Single-center Study
por: Godar, Cassandra M, et al.
Publicado: (2023)

SAT399 Are Gender-affirming Hormone Therapy Duration And Body Mass Index Associated With Bone Mineral Density In Transgender And Gender Diverse Adults?
por: Iwamoto, Sean J, et al.
Publicado: (2023)

SAT420 Bone Health In Transgender People
por: Grande, Giuseppe, et al.
Publicado: (2023)

SAT413 Feminising Gender Affirming Hormone Therapy Prolongs QTc Interval
por: Angus, Lachlan, et al.
Publicado: (2023)

SAT396 Transgender Care From The VA Perspective
por: Nayak, Pratima R
Publicado: (2023)

SAT412 Effects Of Gender-Affirming Hormone Therapy On The Connectivity Of Intrinsic Brain Networks
por: Pedreira, Clarissa C, et al.
Publicado: (2023)

SAT408 Assessment Of Family Planning Readiness In Transgender Youth
por: Conard, Ryan Steven, et al.
Publicado: (2023)

SAT407 Hematospermia In Transgender Woman Revealing Occult Endometriosis
por: Coleman-Belin, Janet C, et al.
Publicado: (2023)

SAT402 A Multimodal Curriculum To Improve Medical Student Gender-affirming Communication Skills
por: Jones, Robert Benson, et al.
Publicado: (2023)

A Cross Sectional Analysis of the Prevalence of Co-Morbidities in Older Transgender Individuals Receiving Hormone Affirming Therapy in Comparison With the General Population
por: Breda, Ido, et al.
Publicado: (2021)

OR31-03 Testosterone Gender-affirming Hormonal Therapy Is Associated With Decreased Cerebral Blood Flow In Transgender Teens
por: Cote, Samantha, et al.
Publicado: (2023)

OR31-06 Gender-Affirming Hormone Therapy Affects Serum Cystatin C-based eGFR In Transgender Individuals
por: van Eeghen, Sarah A, et al.
Publicado: (2023)

SAT391 Supratherapeutic Estrogen Levels in Transgender Women Likely From Sublingual Estradiol
por: Jalal, Erica, et al.
Publicado: (2023)

SAT400 Evaluation Of Lipid Profile Of Transgender Women On Long-Term Estrogen Therapy
por: Mobilia Alvares, Leonardo Azevedo, et al.
Publicado: (2023)

SAT421 Near Term Cardiometabolic Outcomes of Testosterone Therapy In Transgender Boys And Men
por: Dey, Justin, et al.
Publicado: (2023)

SAT417 Comparison Of Mental Health Status In Transgender And Gender Diverse Versus Cisgender People
por: Pedreira, Clarissa C, et al.
Publicado: (2023)

SAT644 Gender Affirming Hormone Therapy (GHAT) In Adult Male-to-female Mice Increases Cortical And Trabecular Bone, Resulting In An Increase In Bone Strength
por: Zajac, Jeffrey D, et al.
Publicado: (2023)

SAT418 Nurse-Led Care For Transgender And Gender Diverse Individuals: A Cross-Sectional Study Of International Context And Practice
por: Greenspan, Debra Lynn, et al.
Publicado: (2023)

SAT393 Resilience And Resistance In The Face Of Stigma And Trauma: A Qualitative Study Of Transgender People’s Reactions To Interactions With The Healthcare System
por: Stroumsa, Daphna, et al.
Publicado: (2023)

SAT403 Long-term Metabolic Effects Of Gonadotropin Releasing Hormone Agonist (GnRH) Therapy In Transgender Women Veterans
por: Le, Guillaume, et al.
Publicado: (2023)

SAT415 Development Of A Novel, Preclinical Swine Model Of Transgender Men To Assess Testosterone Impact On Insulin Sensitivity And Whole-Body Metabolism
por: Mahabir, Nirvana, et al.
Publicado: (2023)

OR31-04 Testosterone Therapy On Gender Dysphoria, Depression, And Suicidality In Transgender And Gender Diverse Individuals Seeking Masculinisation: A Randomised Controlled Trial
por: Nolan, Brendan J, et al.
Publicado: (2023)

PMON280 Effect of Gender Affirming Hormone Therapy (GAHT) on Adipose Tissue Morphology and Metabolism in Transgender Individuals
por: Shah, Manasi S, et al.
Publicado: (2022)

OR25-5 High Prevalence of Psychopathologies Among Transgender Subjects Presenting at a Large Tertiary Transgender Health Center: Implication for the Treating Clinicians
por: Kerem, Gil, et al.
Publicado: (2019)

Approach to the provision of transgender health care in a veteran population
por: Kaigle, Allie, et al.
Publicado: (2018)

Psychiatric admission in adolescent transgender patients: A case series
por: Alastanos, Jennifer N., et al.
Publicado: (2018)

OR31-05 Long-Term Effects Of Gender Affirming Hormone Therapy On Insulin Sensitivity, Insulin Secretion, And Glucose Tolerance
por: Pinkson, Sheila, et al.
Publicado: (2023)

The current status of transgender health education in doctor of pharmacy curricula in North America
por: Wilkening, G. Lucy
Publicado: (2018)

SUN-042 Low Dose Cyproterone Acetate for the Treatment of Transgender Women - a Retrospective Study
por: Even-Zohar, Naomi, et al.
Publicado: (2020)

SAT395 Gender Dysphoria In A Patient With Ovotesticular Disorder Of Sex Development
por: Moreno, Telma, et al.
Publicado: (2023)

SAT397 A Low Dose Cyproterone Acetate In Feminizing Hormone Treatment
por: Korpaisarn, Sira, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6md3gc6hq93k2lnnduka2l4f0b